In spite of the national and international recommendations on the pharmacological iodine supplementation in pregnancy and breastfeeding, the group PrevInfad has failed to find information of quality that permits stablishing a risk-benefit balance of this intervention in Spain. PrevInfad understands that, being a prophylactic intervention that deals with two individuals (mother and child) and that applies to the whole of a healthy population, the precaution principle must apply.
Therefore, PrevInfad considers that there is no evidence of enough quality to stablish the benefits and the risks of pharmacological iodine supplementation during pregnancy and breastfeeding, and suggests not to implement this intervention (recommendation weak against according to GRADE methodology).
Probably, the results of current research will bring in the future essential information that could introduce modifications in this recommendation.
|